Postcards From the End of the Pandemic

One year since the world’s first coronavirus lockdown, China faces new pressure at home and abroad over its pandemic response. Although its success in keeping the infection rate down is undisputed, China’s approach to vaccines is on less stable ground. China has produced two COVID-19 vaccines: one from Sinovac and one from Sinopharm. The country started giving shots to limited groups, including students going abroad, even when the data was still in the early stages, but subsequent trials, largely observed in developing countries, have been disappointing.

Don’t Count on China’s Help With a Coronavirus Inquiry

Don’t Count on China’s Help With a Coronavirus Inquiry The COVID-19 pandemic is far from over. But while many countries are still grappling with how to handle the second wave, a group of international scientists is starting to investigate the origins of the coronavirus and how the next pandemic might be averted. Don’t expect any help from Beijing on this, though. China’s striking success in handling the pandemic has won it plaudits—but it is unlikely to meet international expectations for a transparent, meticulous and meaningful inquiry into the viral spread.